1. Home
  2. LXEO vs ACCD Comparison

LXEO vs ACCD Comparison

Compare LXEO & ACCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • ACCD
  • Stock Information
  • Founded
  • LXEO 2017
  • ACCD 2007
  • Country
  • LXEO United States
  • ACCD United States
  • Employees
  • LXEO N/A
  • ACCD N/A
  • Industry
  • LXEO
  • ACCD Business Services
  • Sector
  • LXEO
  • ACCD Consumer Discretionary
  • Exchange
  • LXEO Nasdaq
  • ACCD Nasdaq
  • Market Cap
  • LXEO 252.4M
  • ACCD 281.1M
  • IPO Year
  • LXEO 2023
  • ACCD 2020
  • Fundamental
  • Price
  • LXEO $4.88
  • ACCD $6.88
  • Analyst Decision
  • LXEO Strong Buy
  • ACCD Buy
  • Analyst Count
  • LXEO 5
  • ACCD 11
  • Target Price
  • LXEO $23.80
  • ACCD $6.36
  • AVG Volume (30 Days)
  • LXEO 210.0K
  • ACCD 3.2M
  • Earning Date
  • LXEO 01-28-2025
  • ACCD 01-10-2025
  • Dividend Yield
  • LXEO N/A
  • ACCD N/A
  • EPS Growth
  • LXEO N/A
  • ACCD N/A
  • EPS
  • LXEO N/A
  • ACCD N/A
  • Revenue
  • LXEO N/A
  • ACCD $446,718,000.00
  • Revenue This Year
  • LXEO N/A
  • ACCD $14.58
  • Revenue Next Year
  • LXEO N/A
  • ACCD $12.65
  • P/E Ratio
  • LXEO N/A
  • ACCD N/A
  • Revenue Growth
  • LXEO N/A
  • ACCD 14.99
  • 52 Week Low
  • LXEO $4.78
  • ACCD $3.08
  • 52 Week High
  • LXEO $19.50
  • ACCD $13.93
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 29.67
  • ACCD 87.13
  • Support Level
  • LXEO $4.78
  • ACCD $6.82
  • Resistance Level
  • LXEO $7.66
  • ACCD $6.90
  • Average True Range (ATR)
  • LXEO 0.56
  • ACCD 0.11
  • MACD
  • LXEO -0.17
  • ACCD 0.28
  • Stochastic Oscillator
  • LXEO 3.47
  • ACCD 98.89

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

About ACCD Accolade Inc.

Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.

Share on Social Networks: